Cushionflor by Congoleum Corporation

Product Description

Cushionflor was a residential and light commercial sheet vinyl flooring product manufactured by Congoleum Corporation during the early 1980s. Produced between 1981 and 1983, Cushionflor was sold as a cushioned, flexible floor covering designed for installation in kitchens, bathrooms, utility rooms, and similar interior spaces. The product belonged to a broader category of resilient sheet flooring that Congoleum had manufactured and marketed throughout much of the twentieth century, a product line that made the company one of the dominant names in the American flooring industry.

Congoleum Corporation, headquartered in Mercerville, New Jersey, had deep roots in the resilient flooring market. The company’s manufacturing operations produced a wide range of vinyl and vinyl-composite flooring products, many of which incorporated asbestos as a functional component during decades when the mineral was considered an industry-standard additive. Cushionflor represented one of the later products in that manufacturing tradition, falling within a narrow production window that extended only through 1983.

Sheet vinyl flooring products of this type were typically sold in rolls and installed by cutting sections to fit a room’s dimensions. The material could be applied using adhesive compounds or left as a loose lay, depending on the installation method and the specific product formulation. Because Cushionflor was designed for consumer-grade applications, it moved through retail flooring outlets, home improvement distributors, and contractor supply channels.

Asbestos Content

Cushionflor contained chrysotile asbestos, the most commercially prevalent form of asbestos used in American manufacturing. Chrysotile, sometimes referred to as white asbestos, is a serpentine mineral fiber that was valued in the flooring industry for several practical properties. When incorporated into vinyl sheet flooring and tile products, chrysotile fibers contributed dimensional stability, resistance to cracking under load, improved tensile strength, and enhanced fire resistance. These characteristics made asbestos an attractive additive in the formulation of resilient flooring materials across the industry.

In sheet vinyl products of this era, asbestos fibers were typically dispersed throughout a backing layer or felt underlayer rather than the surface wear layer. This construction method was intended to give the flooring body, cushioning, and resistance to subfloor imperfections. The asbestos-containing backing layer was integral to the product’s overall structure, meaning that any activity disturbing the material at depth — cutting, grinding, sanding, or tearing — had the potential to release embedded fibers.

The production window of 1981 to 1983 places Cushionflor at the tail end of widespread asbestos use in American flooring manufacturing. By this period, regulatory pressure from the Environmental Protection Agency and the Occupational Safety and Health Administration had prompted many manufacturers to begin transitioning away from asbestos-containing formulations, though the transition was uneven across the industry and not yet complete. Cushionflor’s continued use of chrysotile during this window reflects how asbestos remained present in certain product lines even as regulatory scrutiny intensified.

How Workers Were Exposed

Industrial workers generally represent the primary trade category documented in connection with Cushionflor exposure. This broad designation encompasses individuals who encountered the product in manufacturing, distribution, installation, renovation, and demolition contexts.

Workers involved in the production of Cushionflor at Congoleum’s manufacturing facilities would have encountered chrysotile asbestos during the mixing and incorporation of fiber materials into flooring compounds, during cutting and trimming operations on finished rolls, and during quality control and finishing processes. Manufacturing environments of this type historically generated airborne fiber concentrations from dry asbestos handling, mechanical agitation of asbestos-containing compounds, and inadequate ventilation in production areas.

Flooring installers, maintenance workers, and renovation contractors who worked with Cushionflor after its sale represent another significant exposure category. Cutting sheet vinyl to fit a room required scoring or slicing through the full thickness of the material, including the asbestos-containing backing. Dry-cutting methods, which were common in field installation, could generate respirable fiber dust at the cutting site. Removing existing Cushionflor during renovation or replacement work carried similar risks, particularly when workers pulled, tore, or scraped the material from subfloors. Scraping adhesive residue from underlayers could also disturb asbestos fibers embedded in backing material that had partially separated from the surface layer.

Workers in building trades who performed general demolition of structures containing Cushionflor flooring would have encountered similar hazards. In renovation contexts where floor coverings were disturbed without prior asbestos identification and abatement, workers could be exposed without knowing the material contained regulated fibers. AHERA and OSHA standards developed during and after this period recognized resilient sheet flooring as a category of suspect asbestos-containing material requiring identification before disturbance.

Warehouse and distribution workers who handled Cushionflor in roll form — loading, unloading, cutting sample lengths, or managing damaged inventory — may also have encountered fiber release if rolls were damaged or cut during handling operations.

Documented Trust Fund / Legal Options

Congoleum Corporation does not have an active asbestos trust fund associated with Cushionflor claims. Unlike some asbestos manufacturers who reorganized under Chapter 11 bankruptcy and established Section 524(g) asbestos trusts as part of those proceedings, Congoleum’s situation with respect to Cushionflor does not correspond to a trust mechanism through which standardized claims can be filed for this specific product at this time.

Individuals seeking legal remedies for asbestos exposure linked to Cushionflor must pursue claims through civil litigation rather than trust fund submission.

Litigation records document claims brought against Congoleum Corporation alleging asbestos-related injury connected to its flooring products. Plaintiffs alleged that Congoleum knew or should have known of the hazards associated with chrysotile asbestos in its flooring formulations and failed to provide adequate warnings to workers and consumers who would foreseeably come into contact with the material during installation, maintenance, and removal. Plaintiffs alleged that this failure to warn constituted negligence and exposed workers to an unreasonable risk of asbestos-related disease, including mesothelioma, asbestosis, and asbestos-related lung cancer.

Litigation records document that cases involving Congoleum flooring products were brought in multiple jurisdictions, with claims arising from both occupational and bystander exposure scenarios. Plaintiffs alleged that the company’s marketing and distribution of asbestos-containing flooring without adequate hazard communication left workers without the information necessary to take protective measures.

Anyone with a potential claim related to Cushionflor exposure should consult with a qualified asbestos litigation attorney. Statutes of limitations for asbestos claims vary by state and are typically calculated from the date of diagnosis of an asbestos-related disease rather than the date of exposure. An attorney experienced in asbestos litigation can assess the viability of a claim, identify all potentially liable parties — which may include product distributors, premises owners, and co-defendants beyond the manufacturer — and determine the appropriate jurisdiction for filing.

Medical documentation of an asbestos-related diagnosis, employment records, and any available evidence connecting a claimant to Cushionflor specifically are important elements in building a litigation claim in the absence of a trust fund filing process.